New study tracks Real-World use of kidney drug finerenone in korean patients
NCT ID NCT07232537
First seen Nov 18, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This study observes 500 adults in South Korea with chronic kidney disease and type 2 diabetes who are starting finerenone as part of their routine care. Researchers will collect data on patient characteristics, treatment patterns, and side effects over up to 12 months. The goal is to understand how finerenone is used in real-world settings and to monitor safety, especially high potassium levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many Locations
RECRUITINGMultiple Locations, South Korea
Conditions
Explore the condition pages connected to this study.